NEW YORK, Aug 15 – DeCode of Reykjavik, Iceland reported a 62 percent increase in second-quarter revenues, which rose to $6.2 million, compared with $3.8 million in the year ago period, as the company received increased milestone payments from its drug discovery collaboration with Roche. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.